Imara Lands $31,000,000 Series A Round

  • Feed Type
  • Date
    4/15/2016
  • Company Name
    Imara
  • Mailing Address
    1555 Adams Menlo Park, CA 94025 USA
  • Company Description
    Imara Corporation’s (formerly Lion Cells) mission is to provide superior energy storage solutions and accelerate the adoption of alternative U.S.- based green energy sources.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $31,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funds will allow Imara to develop IMR-687, a disease-modifying therapeutic discovered by H. Lundbeck A/S and selected specifically for the treatment of sickle cell disease and other hemoglobinopathies. Lundbeck granted Imara an exclusive worldwide license and will receive certain milestone payments and royalties on sales as well as minority ownership in Imara.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Lundbeckfond Ventures
  • Venture Investor
    Bay City Capital
  • Venture Investor
    Alexandria Venture Investments

Trending on Xconomy